Sierra Oncology, Inc. SRRA
Set alert
54.99 0.00 0.00%
As of Apr 24, 3:47 PM ET
54.98 Day range 55.01
52-week range unavailable
- Open
- 54.98
- Prev close
- 54.99
- Mkt cap
- 1.34B
- Vol
- 0
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 54.98
- High
- 55.01
- Forward P/E
- -14.25
- Beta
- 0.02
- Short ratio
- 2.41
- Inst. own
- 76.95%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Aug 4, 2022
- 50-d avg
- 54.73
- 200-d avg
- 33.69
- 1y target
- 55.00
Ownership
Held by insiders 8.50%
Held by institutions 76.95%
Float held by institutions 84.10%
Institutions 101
Top institutional holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Vivo Capital, LLC | 13.63% | 3,329,511 | 183.09M | Mar 30, 2022 |
| Frazier Life Sciences Management, L.P. | 9.59% | 2,342,198 | 128.80M | Mar 30, 2022 |
| Orbimed Advisors LLC. | 8.05% | 1,964,770 | 108.04M | Mar 30, 2022 |
| Abingworth, LLP | 5.38% | 1,314,012 | 72.26M | Mar 30, 2022 |
| Rock Springs Capital Management, LP | 4.81% | 1,174,786 | 64.60M | Mar 30, 2022 |
| PFM Health Sciences, LP | 4.35% | 1,062,888 | 58.45M | Mar 30, 2022 |
Top mutual fund holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 1.44% | 351,614 | 19.34M | Mar 30, 2022 |
| BlackRock Health Sciences Trust II | 0.82% | 201,437 | 11.08M | Mar 30, 2022 |
| Blackrock Funds-Health Sciences Opportunity Portfolio | 0.77% | 187,929 | 10.33M | Feb 27, 2022 |
| Gabelli ABC Fund | 0.57% | 138,511 | 7.62M | Jun 29, 2022 |
| Fidelity Select Portfolios - Biotechnology | 0.21% | 52,000 | 2.86M | Mar 30, 2022 |
| Gabelli GDL Fund | 0.18% | 43,231 | 2.38M | Jun 29, 2022 |
Insiders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| ABINGWORTH, L.L.P. | Beneficial Owner of more than 10% of a Class of Security | Purchase | Jan 30, 2022 | 0 |
| AGGARWAL GAURAV | Director and Beneficial Owner of more than 10% of a Class of Security | Purchase | Jan 30, 2022 | 0 |
| ASHIYA MONA PH.D. | Director and Beneficial Owner of more than 10% of a Class of Security | Conversion of Exercise of derivative security | Jan 25, 2022 | 0 |
| LONGITUDE CAPITAL PARTNERS III, L.L.C. | Beneficial Owner of more than 10% of a Class of Security | Purchase | Feb 1, 2022 | 0 |
| ORBIMED ADVISORS, L.L.C. | Beneficial Owner of more than 10% of a Class of Security | Conversion of Exercise of derivative security | Jan 25, 2022 | 0 |
| RICHARDSON JOSHUA | Director and Beneficial Owner of more than 10% of a Class of Security | Purchase | Feb 1, 2022 | 0 |